Development of a Translational Autologous Microthrombi-Induced MINOCA Pig Model.

Autor: Cesarovic N; Department of Health Sciences and Technology, Swiss Federal Institute of Technology, Zurich, Switzerland (N.C., T.S., E.v.G., P.W., V.F., L.G.).; Deutsches Herzzentrum der Charite (DHZC), Department of Cardiothoracic and Vascular Surgery, Berlin, Germany (N.C., J.I., V.F., M.Y.E.)., Weisskopf M; Center for Preclinical Development, University Hospital of Zurich, University of Zurich, Switzerland (M.W., N.E.T., M.M.H., A.L., C.T.S.)., Stolte T; Department of Health Sciences and Technology, Swiss Federal Institute of Technology, Zurich, Switzerland (N.C., T.S., E.v.G., P.W., V.F., L.G.)., Trimmel N; Center for Preclinical Development, University Hospital of Zurich, University of Zurich, Switzerland (M.W., N.E.T., M.M.H., A.L., C.T.S.)., Hierweger MM; Center for Preclinical Development, University Hospital of Zurich, University of Zurich, Switzerland (M.W., N.E.T., M.M.H., A.L., C.T.S.)., Hoh T; Institute for Biomedical Engineering, University and ETH Zurich, Switzerland (T.H., C.W., C.T.S., S.K.)., Iske J; Deutsches Herzzentrum der Charite (DHZC), Department of Cardiothoracic and Vascular Surgery, Berlin, Germany (N.C., J.I., V.F., M.Y.E.)., Waschkies C; Institute for Biomedical Engineering, University and ETH Zurich, Switzerland (T.H., C.W., C.T.S., S.K.)., Chen JL; Department of Mechanical and Process Engineering, University and ETH Zurich, Switzerland (J.L.C.)., van Gelder E; Department of Health Sciences and Technology, Swiss Federal Institute of Technology, Zurich, Switzerland (N.C., T.S., E.v.G., P.W., V.F., L.G.)., Leuthardt A; Center for Preclinical Development, University Hospital of Zurich, University of Zurich, Switzerland (M.W., N.E.T., M.M.H., A.L., C.T.S.)., Glaus L; Department of Health Sciences and Technology, Swiss Federal Institute of Technology, Zurich, Switzerland (N.C., T.S., E.v.G., P.W., V.F., L.G.)., Rösch Y; ARTORG Center for Biomedical Engineering Research, University of Bern, Switzerland (Y.R., D.O.)., Stoeck CT; Center for Preclinical Development, University Hospital of Zurich, University of Zurich, Switzerland (M.W., N.E.T., M.M.H., A.L., C.T.S.).; Institute for Biomedical Engineering, University and ETH Zurich, Switzerland (T.H., C.W., C.T.S., S.K.)., Wolint P; Department of Health Sciences and Technology, Swiss Federal Institute of Technology, Zurich, Switzerland (N.C., T.S., E.v.G., P.W., V.F., L.G.)., Obrist D; ARTORG Center for Biomedical Engineering Research, University of Bern, Switzerland (Y.R., D.O.)., Kozerke S; Institute for Biomedical Engineering, University and ETH Zurich, Switzerland (T.H., C.W., C.T.S., S.K.)., Falk V; Department of Health Sciences and Technology, Swiss Federal Institute of Technology, Zurich, Switzerland (N.C., T.S., E.v.G., P.W., V.F., L.G.).; Deutsches Herzzentrum der Charite (DHZC), Department of Cardiothoracic and Vascular Surgery, Berlin, Germany (N.C., J.I., V.F., M.Y.E.).; Charité-Universitätsmedizin Berlin, Germany (V.F., M.Y.E.).; Deutsches Zentrum für Herz-Kreislaufforschung, Partner Site Berlin, Germany (V.F., M.Y.E.)., Emmert MY; Deutsches Herzzentrum der Charite (DHZC), Department of Cardiothoracic and Vascular Surgery, Berlin, Germany (N.C., J.I., V.F., M.Y.E.).; Charité-Universitätsmedizin Berlin, Germany (V.F., M.Y.E.).; Deutsches Zentrum für Herz-Kreislaufforschung, Partner Site Berlin, Germany (V.F., M.Y.E.).; Institute for Regenerative Medicine (IREM), University of Zurich, Switzerland (M.Y.E.).

Publikováno v: Circulation research [Circ Res] 2023 Jul 21; Vol. 133 (3), pp. 291-293. Date of Electronic Publication: 2023 Jul 03.

Pathology and Advanced Imaging-Characterization of a Congenital Cardiac Defect and Complex Hemodynamics in a Pig: A Case Report.

Autor: Malbon AJ; Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland., Weisskopf M; Center for Surgical Research, University of Zurich, University Hospital of Zurich, Zurich, Switzerland., Glaus L; Translational Cardiovascular Technologies, Department of Health Sciences and Technology, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland., Neuber S; Cardiosurgical Research Group, Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.; Translational Cardiovascular Regenerative Technologies Group, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, Germany., Emmert MY; Cardiosurgical Research Group, Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.; Translational Cardiovascular Regenerative Technologies Group, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies, Berlin, Germany.; Institute for Regenerative Medicine, University of Zurich, Zurich, Switzerland., Stoeck CT; Institute for Biomedical Engineering, Department of Information Technology and Electrical Engineering, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland., Cesarovic N; Center for Surgical Research, University of Zurich, University Hospital of Zurich, Zurich, Switzerland.; Translational Cardiovascular Technologies, Department of Health Sciences and Technology, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland.; Cardiosurgical Research Group, Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.

Publikováno v: Frontiers in veterinary science [Front Vet Sci] 2021 Dec 06; Vol. 8, pp. 790019. Date of Electronic Publication: 2021 Dec 06 (Print Publication: 2021).

Unmasking of the hypotensive effect of nifedipine in normotensives by addition of the angiotensin converting enzyme inhibitor benazepril

Autor: Degen P, Joël Ménard, Bellet M, Glaus L, Maurice Np, Graf P, Jakobsen J

Publikováno v: Journal of hypertension. 10(9)

OBJECTIVE To study the pharmacological interaction between a dihydropyridine derivative (nifedipine slow release 20 mg) and inhibition of the renin-angiotensin system (benazepril 10 mg). DESIGN Single application at intervals of 2 weeks in an open-la

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11941c4c9263322d33fc7a62e0bbd0fa
https://pubmed.ncbi.nlm.nih.gov/1328364

1200 mg Rifampicin (Rimactan®) als Einzeldosisbehandlung der unkomplizierten Gonorrhoe der Frau.

Autor: Schwarzenbach, H.R., Rufli, Th., Glaus, L., Bergamini, N.

Publikováno v: Dermatologica; 1983, Vol. 167 Issue 5, p262-266, 5p

Sind Varizenträger venenkrank?

Autor: Widmer Lk, Glaus L, Schneider M, Leu Hj

Publikováno v: DMW - Deutsche Medizinische Wochenschrift. 98:343-346

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ea66c755195fb0d9c6fdd6af9404836
https://doi.org/10.1055/s-0028-1106810